Ajanta Pharma informs about loss of share certificate

24 Feb 2023 Evaluate

Pursuant to Regulation 39(3) and other applicable regulations of SEBI Listing Regulations, Ajanta Pharma has informed that Registrar and Transfer Agent of Company - Link Intime India has received intimation for loss of share certificate and request for issuance of duplicate share certificate from the shareholder, Aote Ashish Annaji (Folio No: 0005363). As required under the SEBI Circular No. SEBI /HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th May, 2022, Registrar and Transfer Agent will issue ‘Letter of Confirmation’ in lieu of physical duplicate share certificate, after necessary due diligence. Further details are enclosed.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2377.00 143.90 (6.44%)
03-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.